US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 778.070
- +6.070+0.79%
Close Jan 2 16:00 ET
- 778.070
- 0.0000.00%
Post 20:01 ET
738.63BMarket Cap84.12P/E (TTM)
787.000High771.770Low1.94MVolume780.590Open772.000Pre Close1.51BTurnover0.21%Turnover Ratio134.15P/E (Static)949.32MShares970.91652wk High51.87P/B737.05BFloat Cap605.62252wk Low5.03Dividend TTM947.28MShs Float970.916Historical High0.65%Div YieldTTM1.97%Amplitude5.278Historical Low778.848Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Eli Lilly and Co Stock Forum
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
Nothing goes up forever, when it’s time for the fall, it just fall. You can lame it on FED or Powell but this pull back is a healthy one and an opportunity to buy the dip.
Once stable, we will probably see the the stocks trading around the same level until early next year. Hopefully by then the earnings season will provide some fuel for the stocks to move up.
$Eli Lilly and Co (LLY.US)$ $Tesla (TSLA.US)$ $Advanced Micro Devices (AMD.US)$ $Apple (AAPL.US)$ $Novo-Nordisk A/S (NVO.US)$ $Arm Holdings (ARM.US)$
...
Gapping up
$FedEx (FDX.US)$ stock soared 8.6% after the delivery giant reported better-than-expected earnings in the fiscal second quarter, while also announcing that it’s planning on spinning off its freight business.
$Eli Lilly and Co (LLY.US)$ stock rose 5.5%, with the drugmaker’s gains reflecting growing confidence in its competing obesity treatments.
Gapping down
$Nike (NKE.US)$ stock slumped 7.4% after the sports...
No comment yet